1. Behavioural responses of young anaemic Indian children to iron-folic acid supplements were assessed in two separate studies using the Indian adaptation of Wechsler's (1967) intelligence scale for children (WISC).2. The first study was an exploratory study in which the cognitive behaviour of 5-8-year-old children of both sexes was assessed before and after supplementation with 20 mg elemental Fe and 0.1 mg folic acid given daily for a period of 60 d.3. The supplemented children showed a significant improvement in haemoglobin (Hb) as well as the WISC scores while the control children who did not receive any supplements failed to show an improvement either in Hb or in the WISC scores. However, within the supplemented group when the initially-anaemic children were compared with the initially-non-anaemic ones, only the 7-year-old anaemic children performed significantly poorer in the tests than the non-anaemic group of the same age. The study raised the possibility that in addition to increasing the blood Hb levels, Fe-folic acid supplements may have additional benefits in improving the cognitive performance of children.4. In the second study, cognitive behaviour of fourteen matched pairs of anaemic children in the age-range of 5-6 years was assessed before and after supplementation with 40 mg Fe and 0.2 mg folk acid given daily in two divided doses or sugar placebos for a period of 60 d. The tester did not know the group to which each child belonged.5. The supplemented children showed a significant improvement in Hb as well as in the verbal and performance IQ of WISC. The control children showed no improvement in Hb but their verbal IQ improved significantly. However, there was no significant improvement in their performance IQ.6. The results indicated that Fe-folic acid supplements to anaemic children not only raised Hb levels but also improved intelligence'test results, particularly in the performance section.
Background We report a case-series of Ayurvedic treatment in seven COVID-19 positive patients with multiple comorbidities, categorized as high risk for poor outcome from SARS-CoV-2 infection. All of them recovered completely from their illness with resolution of symptoms following Ayurvedic treatment. The data was collected from patients treated during the early months of the COVID-19 pandemic (June 2020 to September 2020) at an out-patient Ayurvedic Clinic, Chennai, India. Clinical Presentation This is a retrospective case series from among the initial 247 COVID-19 patients out of whom 39% were found to be suffering from comorbidities. We have chosen seven of these patients who fulfilled the criteria for high-risk category, represented by multiple comorbidities that included cancer, chronic kidney disease (CKD), coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), hypertension and an elderly person over the age of 90 years. Intervention Classical Ayurvedic formulations for COVID -19 were chosen so as to avoid complicating co-morbid conditions and patients were maintained on a modified diet. All these high-risk patients were treated at an outpatient setting. The patients were under home quarantine and self-monitored their progress with daily follow up over the phone by the treating Ayurvedic physician. Outcomes and Conclusions The main outcome measure included resolution of symptoms and complete recovery from COVID-19 disease in all patients. This case series demonstrates the scope of Ayurvedic interventions in management of high risk COVID-19 patients with severe comorbidities with successful outcome in an out-patient setting.
This article reports the treatment outcomes of 167 COVID-19 positive patients who were treated with stand-alone Ayurvedic therapeutic intervention. The main outcomes are quick resolution of symptoms, no deterioration in any of the cases and safe treatment for patients with multiple comorbidities. There was no observed mortality. There were no adverse events due to the Ayurvedic medications. The treatment was undertaken in an out-patient setting and at a low cost. The efficacy and safety of the treatment, and the quick resolution of symptoms are demonstrated. This shows that if COVID-19 patients are treated with Ayurvedic medicines early in the course of COVID-SARS-2 infection, Ayurveda has the potential to prevent progression and deterioration of the disease, with decreased morbidity and mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.